ACM
IONS icon

Aquatic Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Aquatic Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
147,379
+14,553
+11% +$1.15M 0.32% 76
2025
Q4 		$10.5M Sell
132,826
-26,219
-16% -$1.97M 0.3% 76
2025
Q3 		$10.4M Buy
159,045
+959
+0.6% +$46.8K 0.19% 129
2025
Q2 		$6.25M Buy
158,086
+1,929
+1% +$63.1K 0.13% 206
2025
Q1 		$4.71M Sell
156,157
-73,859
-32% -$2.42M 0.12% 225
2024
Q4 		$8.04M Buy
+230,016
New +$8.6M 0.22% 121
2024
Q2 		– Sell
-11,700
Closed -$507K – 1407
2024
Q1 		$507K Buy
11,700
+5,300
+83% +$253K 0.02% 541
2023
Q4 		$324K Buy
+6,400
New +$307K 0.01% 738
2023
Q1 		– Sell
-3,200
Closed -$121K – 1499
2022
Q4 		$121K Sell
3,200
-22,300
-87% -$938K 0.01% 836
2022
Q3 		$1.13M Buy
+25,500
New +$1.07M 0.11% 240

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's IONS Position: Q1 2026 in Review

Aquatic Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 11% in Q1 2026, buying an estimated $1.15M and bringing the position to 147,379 shares worth $11.1M. The position accounts for 0.32% of the portfolio, ranked #76.

Aquatic Capital Management first reported a position in IONS in Q3 2022 and has held it in 10 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Aquatic Capital Management held 147,379 shares of Ionis Pharmaceuticals worth $11.1M as of Q1 2026.
  • Aquatic Capital Management bought 14,553 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
  • Ionis Pharmaceuticals made up 0.32% of Aquatic Capital Management's portfolio in Q1 2026, its #76 holding.
  • Aquatic Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.